Medicine recalls
|
| |
| Canada: Recall: Apo-Risperidone Solution 1mg/ml |
| |
Apotex Inc. is recalling one batch of Apo-Risperidone Solution 1mg/ml (lot no.: KV2168) to the wholesaler level as the product lot may not meet organic impurity specifications throughout the shelf life of the product. Health Canada classified the hazard level of the recall as Type III, i.e. a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../53321r-eng.php
In Hong Kong, Apo-Risperidone Oral Solution 1mg/ml (HK-57547) is a pharmaceutical product registered by Hind Wing Co. Ltd. (Hind Wing), and is a prescription-only medicine. On 29 April 2015, Hind Wing notified the Department of Health (DH) of the incident, and confirmed that the affected batch KV2168 had been imported into Hong Kong and was distributed to private doctors. So far, the DH has not received any adverse drug reaction report related to the product. In line with the Health Canada announcement to recall the product batch to the wholesaler level, Hind Wing had quarantined the remaining stock of the affected product batch for disposal. The DH will continue to remain vigilant on the development of the incident, and will follow-up accordingly.
Ends/ Friday, May 08, 2015
Issued at HKT 14:00
|
| |
|
